Year: 2021
Language: English
This resource is also available in:
In this final session from the Global Policy and Access Summit, Salome Mekhuzla, David Page, Mukesh Garodia and Antonio Gomez Cavallini discuss how the global bleeding disorders community is sustaining and advancing care today and in the post-pandemic world. They will also cover the strategies that have proven successful, and what contributions various stakeholders bring in achieving a more equitable access to treatment and care for people with bleeding disorders globally.
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.
A summary of discussions held at the Fourteenth WFH Global Forum on Advances and Access to Safe Treatment Products for
Also Available In: English, Spanish, French, Arabic, Russian, Simplified Chinese This is not an official WFH translation. This resource has
The WFH Guidelines for the Management of Hemophilia: AAV Gene Therapy provide the first comprehensive, evidence-based recommendations to support the
Raising funds requires careful research and detailed planning, as well as creativity and good business practices. The second edition of
The 2026 version is available in: SpanishThe 2018 version booklet is available in: English, Arabic, French, Russian, Spanish, Simplified Chinese Using
The 3rd edition has also been translated into the following languages, with permission from the WFH, by NMOs/Other Organizations: Georgian,